TScan Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:TCRX Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
23 Dec 25	BuyUS$145,526	Lynx1 Capital Management LP	Company		161,801	US$0.90

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of TCRX?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	119,767	0.183%
Hedge Funds	5,564,290	8.51%
Institutions	27,566,605	42.2%
General Public	32,100,155	49.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.5%.

Top Shareholders

Top 25 shareholders own 48.52% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
12.3%	Lynx1 Capital Management LP	8,019,148	US$7.3m	0%	1.08%
8.51%	BVF Partners L.P.	5,564,290	US$5.1m	6.47%	0.15%
4.26%	Baker Bros. Advisors LP	2,784,792	US$2.5m	0%	0.01%
3.3%	Vanguard Capital Management, LLC	2,154,256	US$2.0m	0%	no data
2.82%	BlackRock, Inc.	1,840,952	US$1.7m	-0.42%	no data
2.23%	Millennium Management LLC	1,460,285	US$1.3m	262%	no data
2.09%	Renaissance Technologies LLC	1,364,783	US$1.2m	19.6%	no data
1.91%	Deer Management Co. LLC	1,245,504	US$1.1m	0%	0.08%
1.85%	Two Sigma Investments, LP	1,209,009	US$1.1m	85.7%	no data
1.4%	Aberdeen Group Plc	918,020	US$837.3k	-48.6%	no data
1.24%	Jacobs Levy Equity Management Inc	808,356	US$737.3k	330%	no data
1.02%	DC Investments Management, LLC	665,563	US$607.1k	0%	0.22%
0.94%	Geode Capital Management, LLC	616,952	US$562.7k	9.75%	no data
0.72%	K2 HealthVentures	467,904	US$426.8k	0%	no data
0.58%	GSA Capital Partners LLP	378,960	US$345.7k	67.6%	0.02%
0.49%	D. E. Shaw & Co., L.P.	319,587	US$291.5k	360%	no data
0.49%	Citadel Advisors LLC	318,411	US$290.4k	95.5%	no data
0.47%	Vanguard Fiduciary Trust Company	305,772	US$278.9k	0%	no data
0.36%	Marshall Wace LLP	237,346	US$216.5k	-30%	no data
0.32%	State Street Global Advisors, Inc.	207,313	US$189.1k	0%	no data
0.31%	Acadian Asset Management LLC	201,987	US$184.2k	584%	no data
0.27%	Morgan Stanley	173,643	US$158.4k	-23.1%	no data
0.24%	Susquehanna International Group, LLP	157,228	US$143.4k	-27.3%	no data
0.22%	Jane Street Group, LLC	144,421	US$131.7k	-62.8%	no data
0.22%	Brown Brothers Harriman & Co.	143,051	US$130.5k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/14 05:05
End of Day Share Price	2026/06/12 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

TScan Therapeutics, Inc. is covered by 9 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Andrew Fein	H.C. Wainwright & Co.
Andres Maldonado	H.C. Wainwright & Co.
Christopher Howerton	Jefferies LLC